Work

P2.06-08 Phase I/II Study of Rucaparib and Pembrolizumab Maintenance in Stage IV NSCLC after Carboplatin, Pemetrexed, Pembrolizumab

Year: 2023

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2023.09.554

Authors: A. Qin, D. Morgensztern, S. Waqar, D. Owen, S. Gadgeel, B. Schneider, G. Kalemkerian, J. Rice, N. Ramnath

Institutions: University of Michigan, Washington University in St. Louis, The Ohio State University, VA Ann Arbor Healthcare System

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4388045231

FWCI:

Cites:

Cited by:

Related to: 10